Duke Human Vaccine Institute
Durham
About Duke Human Vaccine Institute
The Duke Human Vaccine Institute develops vaccines and therapeutics against diseases of global importance.The investigators at the DHVI conduct basic and translational research to develop novel vaccines, therapeutics and diagnostics for diseases
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $10K – $50K
- Total funding: $43.4M
- Last round: Grant (Oct 2022)
- Website: dhvi.duke.edu
- Phone: 919-684-5384
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/duke-human-vaccine-institute-104760 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.